date,title,source
Oct-22-18,"Why Celldex Therapeutics, Inc. Fell on Monday",Motley Fool
Nov-01-18,"Why Shares of Celldex Therapeutics, Inc. Sailed Higher Today",Motley Fool
Nov-07-18,"Celldex Therapeutics (CLDX) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-07-18,Celldex: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Celldex Provides Corporate Update and Reports Third Quarter 2018 Results,GlobeNewswire
Nov-08-18,"Here's Why Celldex Therapeutics, Inc. Surged on Thursday",Motley Fool
Nov-08-18,Celldex Therapeutics Inc. Chugs Along in the 3rd Quarter Despite Challenges,Motley Fool
Nov-09-18,"Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss",Zacks
Nov-09-18,Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunotherapy of Cancers 33rd Annual Meeting,GlobeNewswire
Nov-26-18,"Analysis: Positioning to Benefit within Celldex Therapeutics, InnSuites Hospitality Trust, Keryx Biopharmaceuticals, EMX Royalty, FTE Networks, and Xinyuan Real Estate  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
